Page last updated: 2024-10-25

desipramine and Arterial Occlusive Diseases

desipramine has been researched along with Arterial Occlusive Diseases in 1 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bouvier, M1
de Champlain, J1

Other Studies

1 other study available for desipramine and Arterial Occlusive Diseases

ArticleYear
Selective activation of the adrenal medulla during acute bilateral carotid occlusion and its modulation by alpha-adrenergic receptors in the rat.
    Canadian journal of physiology and pharmacology, 1983, Volume: 61, Issue:4

    Topics: Adrenal Medulla; Adrenalectomy; Animals; Arterial Occlusive Diseases; Blood Pressure; Carotid Artery

1983